EUVIMEDEUVIMED entdecken
Crossref

Levodopa-induced Dyskinesia in Parkinson’s Disease: Plausible Inflammatory and Oxidative Stress Biomarkers

Swagata Sarkar iD, Akash Roy iD, Supriyo Choudhury iD, Rebecca Banerjee, Sanjit Dey iD, Hrishikesh Kumar iD

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2024

DOI: 10.1017/cjn.2023.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2024. Verfasst von Swagata Sarkar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Institute of Neurosciences Kolkata, Kolkata, India. Hauptthemen laut MEDLINE: Parkinson Disease, Dyskinesia, Drug-Induced. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathophysiology of levodopa-induced dyskinesia (LID) remains obscure. Increased dopamine metabolism due to prolonged levodopa treatment can exacerbate oxidative damage and neuroinflammatory pathology in Parkinson’s disease (PD). Association of novel peripheral markers with LID severity might provide insight into LID pathomechanisms.

Objective

We aimed to study specific peripheral blood inflammatory-oxidative markers in LID patients and investigate their association with clinical severity of LID.

Method

Motor, non-motor and cognitive changes in PD with and without LID compared to healthy-matched controls were identified. Within the same cohort, inflammatory marker (sLAG3, TOLLIP, NLRP3 and IL-1β) levels and antioxidant enzyme activities were determined by ELISA and spectrophotometric methods.

Results

LID patients showed distinctly upregulated TOLLIP, IL-1β levels with significant diminution of antioxidant activity compared to controls. Significant negative association of cognitive markers with oxidative changes was also observed.

Conclusion

To our understanding, this is the first study that indicates the involvement of toll-like receptor-mediated distinct and low-grade inflammatory activation in LID pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDyskinesia, Drug-InducedHumansLevodopaAntiparkinson AgentsBiomarkersOxidative Stress

Stichwörter der Autor:innen

InflammationLevodopa-induced dyskinesiaNLRP3Oxidative markersTollipsLAG-3

Substanzen

LevodopaAntiparkinson AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Institute of Neurosciences Kolkata, Kolkata, India.
  • Department of Physiology, University of Calcutta, Kolkata, India.

ORCID-Profile: Swagata Sarkar, Akash Roy, Supriyo Choudhury, Sanjit Dey, Hrishikesh Kumar

Zitieren

APA

Sarkar, S., Roy, A., Choudhury, S., Banerjee, R., Dey, S., & Kumar, H. (2024). Levodopa-induced Dyskinesia in Parkinson’s Disease: Plausible Inflammatory and Oxidative Stress Biomarkers. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2023.8

Vancouver

Sarkar S, Roy A, Choudhury S, Banerjee R, Dey S, Kumar H. Levodopa-induced Dyskinesia in Parkinson’s Disease: Plausible Inflammatory and Oxidative Stress Biomarkers. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2024. doi:10.1017/cjn.2023.8

BibTeX
@article{Sarkar2024,
  author = {Sarkar, Swagata and Roy, Akash and Choudhury, Supriyo and Banerjee, Rebecca and Dey, Sanjit and Kumar, Hrishikesh},
  title = {Levodopa-induced Dyskinesia in Parkinson’s Disease: Plausible Inflammatory and Oxidative Stress Biomarkers},
  journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
  year = {2024},
  doi = {10.1017/cjn.2023.8}
}
Kostenlos starten →